Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492

Transforming gene product of Rous sarcoma virus phosphorylates tyrosine

Hunter, T. R., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,333

A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau

Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418

D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA

Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021

Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.

Wischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4506 · Cited by 939

A family of human cdc2‐related protein kinases.

Meyerson, M. M., Enders, G. H., Wu, C. L., Su, L., Gorka, C., Nelson, C. E., Harlow, E., & Tsai, L. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05360.x · Cited by 925

Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly

Cleveland, D. W., Hwo, S. Y., & Kirschner, M. W. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90214-5 · Cited by 881

Different Effects and Mechanisms of Selenium Compounds in Improving Pathology in Alzheimer’s Disease

Zhang, Z., Peng, J., Chen, Y., Wang, C., Chen, C., & Song, G.-L. (2023) · Antioxidants · doi:10.3390/antiox12030702 · Cited by 23

The Xenopus laevis homologue to the neuronal cyclin-dependent kinase (cdk5) is expressed in embryos by gastrulation

Gervasi, C., & Szaro, B. G. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00109-6 · Cited by 22

Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse

Ontiveros‐Torres, M. Á., Labra‐Barrios, M. L., Díaz-Cintra, S. Y., Aguilar-Vázquez, A. R., Moreno-Campuzano, S., Flores-Rodríguez, P., Luna-Herrera, C., Mena, R., Perry, G. L., Florán, B., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150837 · Cited by 21

Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules

Shea, T. B., & Fischer, I. (1996) · FEBS Letters · doi:10.1016/0014-5793(95)01411-x · Cited by 20

The Order of Exposure of Tau to Signal Transduction Kinases Alters the Generation of “AD-Like” Phosphoepitopes

Shea, T. B., & Cressman, C. M. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006977127422 · Cited by 19

Phosphorylation events mediated by protein kinase Cα and ε participate in regulation of tau steady‐state levels and generation of certain “Alzheimer‐like” phospho‐epitopes

Boyce, J. J., & Shea, T. B. (1997) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(97)00010-5 · Cited by 18

Phosphorylation by Cyclin-Dependent Protein Kinase 5 Of The Regulatory Subunit (Pγ) Of Retinal cGMP Phosphodiesterase (PDE6): Its Implications In Phototransduction

Yamazaki, A., Moskvin, O. V., & Yamazaki, R. K. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0121-3_9 · Cited by 18

Fluorescent biosensors for drug discovery new tools for old targets – Screening for inhibitors of cyclin-dependent kinases

Prével, C., Kurzawa, L., Van, T. N. N., & Morris, M. C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.003 · Cited by 22

Synthesis and conformational properties of phosphopeptides related to the human tau protein

Du, J., Li, Y., Ma, Q., Wei, Q., Zhao, Y., Abe, H., Kanazawa, K., Qin, X., Aoyagi, R., Ishizuka, Y., et al. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.03.003 · Cited by 17

APPsα rescues CDK5 and GSK3β dysregulation and restores normal spine density in Tau transgenic mice

Baltissen, D., Bold, C. S., Rehra, L., Banićević, M., Fricke, J., Just, J., Ludewig, S., Buchholz, C. J., Körte, M., & Müller, U. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1106176 · Cited by 18

Cyclin-dependent kinase 5 is associated with risk for Alzheimer’s disease in a Dutch population-based study

Vásquez, A. A., Aulchenko, Y. S., Isaacs, A. J., Oosterhout, A., Sleegers, K., Hofman, A., Broeckhoven, C. V., Oostra, B. A., Breteler, M. M. B., & van Duijn, C. M. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0770-5 · Cited by 16

Effect of heparin on phosphorylation site specificity of neuronal Cdc2‐like kinase

Qi, R. Z., Zhu, X., Goedert, M., Fujita, D. J., & Wang, J. H.-C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00096-9 · Cited by 16

Kinetic Mechanistic Studies of Cdk5/p25-Catalyzed H1P Phosphorylation: Metal Effect and Solvent Kinetic Isotope Effect

Liu, M., Girma, E., Glicksman, M. A., & Stein, R. L. (2010) · Biochemistry · doi:10.1021/bi100244j · Cited by 15

Widespread hyperphosphorylated tau in the working memory circuit early after cortical impact injury of brain (Original study)

Zhao, Z., Ning, Y., Li, P., Yang, N., Peng, Y., Xiong, R., Zhao, Y., Liu, D., Zeng, X., Chen, J., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.02.002 · Cited by 15

A Drosophila CDK5α-like Molecule and Its Possible Role in Response to O2 Deprivation

Ma, E., & Haddad, G. G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1069 · Cited by 15

Identification and Structure Characterization of a Cdk Inhibitory Peptide Derived from Neuronal-specific Cdk5 Activator

Chin, K., Ohki, S., Tang, D., Cheng, H., Wang, J. H.-C., & Zhang, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7120 · Cited by 15

Neurofilaments are part of the high molecular weight complex containing neuronal cdc2-like kinase (nclk)

Lee, K.-Y., & Johnston, R. N. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00508-8 · Cited by 15

P39 immunoreactivity in glial cytoplasmic inclusions in brains with multiple system atrophy

本城, 靖., Kawamoto, Y., Nakamura, S., Nakano, S., & Akiguchi, I. (2001) · Acta Neuropathologica · doi:10.1007/s004010000246 · Cited by 15

Development of an Assay to Screen for Inhibitors of Tau Phosphorylation by Cdk5

Ahn, J. S., Musacchio, A., Mapelli, M., Ni, J., Scinto, L. F. M., Stein, R. L., Kosik, K. S., & Yeh, L.-A. (2004) · SLAS DISCOVERY · doi:10.1177/1087057103260594 · Cited by 13

Regulation of microtubule-associated proteins, protein kinases and protein phosphatases during differentiation of SY5Y cells

Haque, N., Gong, C., Sengupta, A., Iqbal, K., & Grundke, I. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.07.001 · Cited by 13

Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells

Clementi, L., Sabetta, S., Zelli, V., Compagnoni, C., Tessitore, A., Mattei, V., & Angelucci, A. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04721-2 · Cited by 11

Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America

Cardona‐Gómez, G. P., & Lopera, F. J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00304 · Cited by 11

Explaining the inhibition of cyclin-dependent kinase 5 by peptides derived from p25 with molecular dynamics simulations and MM-PBSA

Tan, V. B. C., Zhang, B., Lim, K. M., & Tay, T. E. (2009) · Journal of Molecular Modeling · doi:10.1007/s00894-009-0514-1 · Cited by 11

Epigenetics, Brain and Behavior

Sassone‐Corsi, P., & Christen, Y. (2012) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-27913-3 · Cited by 11

Molecular and cellular events of dopamine D1 receptor‐mediated tau phosphorylation in SK‐N‐MC cells

Lebel, M., & Cyr, M. (2010) · Synapse · doi:10.1002/syn.20818 · Cited by 10

The topography and subcellular distribution ofmitogen-activated protein kinase kinase 1 (MEK1) inadult rat brain and differentiating PC12 cells

Schipper, H. M., Agarwal-Mawal, A., & Paudel, H. K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00120-7 · Cited by 10

Regulatory properties of neuronal cdc2-like kinase

Qi, R. Z., Tang, D., Matsuura, I., Lee, K., Zhu, X., Huang, Q.-Q., & Wang, J. H.-C. (1995) · Molecular and Cellular Biochemistry · doi:10.1007/bf01076561 · Cited by 10

Drosophila cdk5 is needed for locomotive behavior and NMJ elaboration, but seems dispensable for synaptic transmission

Kissler, A. E., Pettersson, N., Frölich, A. M., Sigrist, S. J., & Suter, B. (2009) · Developmental Neurobiology · doi:10.1002/dneu.20711 · Cited by 9

Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase

Chen, X., & Igumenova, T. I. (2022) · Advances in Biological Regulation · doi:10.1016/j.jbior.2022.100938 · Cited by 11

Cognitive Function in Health and Disease: The Role of Epigenetic Mechanisms

Mungenast, A. E., & Tsai, L. (2012) · Neurodegenerative Diseases · doi:10.1159/000334602 · Cited by 9

Strategizing the Development of Alzheimer’s Therapeutics

Davis, J. B., & Couch, R. D. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.33011 · Cited by 7

The attenuation effect of potassium 2‐(1‐hydroxypentyl)‐benzoate in a mouse model of diabetes‐associated cognitive decline: The protein expression in the brain

Yu, W., Yin, H., Sun, Y., Shi, S., Li, J., & Wang, X. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13847 · Cited by 7

Mitogen‐activated protein kinase activity may not be necessary for the neuropathology of Niemann–Pick type C mice

Zhang, M., Hallows, J. L., Wang, X., Bu, B., Wang, W., & Vincent, I. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05657.x · Cited by 8

Determination of kinetic parameters and structure–activity relationships of ginsenosides as inhibitors of cyclin‐dependent kinase 5/p25 using ultra‐pressure liquid chromatography with triple quadrupole tandem mass spectrometry

Chen, N., Yang, H., Niu, J., & Liu, S. (2013) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.6537 · Cited by 7

Prospect of Therapeutic Approaches to Tauopathies

Roder, H. M. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:2:195 · Cited by 7

Tau proteins and their significance in the pathobiology of Alzheimer's disease

Lee, V. M. ‐., & Trojanowski, J. Q. (1995) · Elsevier eBooks · doi:10.1016/b978-012286965-5/50005-4 · Cited by 7

Involvement of cyclin-dependent kinase 5 in 2,5-hexanedione-induced neuropathy

Wang, Q., Zhang, C., Hou, L., Zhao, X., Yang, X., & Xie, K. (2008) · Toxicology · doi:10.1016/j.tox.2008.02.019 · Cited by 6

Che-1 enhances cyclin-dependent kinase 5 expression and interacts with the active kinase-complex

Buontempo, S., Barbato, C., Bruno, T., Corbi, N., Ciotti, M. T., Floridi, A., Fanciulli, M., & Passananti, C. (2008) · Neuroreport · doi:10.1097/wnr.0b013e3282f85c1b · Cited by 5

Beyond Secretases

Medda, F., Smith, B. E., Gokhale, V. M., Shaw, A. Y., Dunckley, T. L., & Hulme, C. (2013) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-417150-3.00005-3 · Cited by 5

Induction of lysosomal abnormalities and tau hyperphosphorylation in human neuroblastoma cells by colchicine and okadaic acid: Evidence that microtubule disruption contributes to Alzheimer neurodegeneration

Shea, T. B. (1996) · Neuroscience Research Communications · doi:10.1002/(sici)1520-6769(199607)19:1 · Cited by 5

Effect of GAPT extract on expression of tau protein and its phosphorylation related enzymes in hippocampal neurons of APPV717I transgenic mice

Ni, J., Shi, J., Zhang, X., Yang, Y., Liu, X., Wei, M., Li, T., Wang, P., Tian, J., & Wang, Y.-Y. (2017) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-017-2545-7 · Cited by 4

Role of tau in Alzheimer's dementia and other neurodegenerative diseases

Quadros, A., Weeks, O. I., & Ait‐Ghezala, G. (2007) · Journal of Applied Biomedicine · doi:10.32725/jab.2007.001 · Cited by 4

NEURONAL FUNCTIONS OF PROTEIN PHOSPHATASE 2A

Leung, H. (2013) · Neuroscience International · doi:10.3844/amjnsp.2013.46.55 · Cited by 3

Purification and Characterization of a p13Suc1‐Bound Serine/Threonine Kinase that is Expressed in Mature Rat Brain

Tamaru, T., & Okacta, M. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0152q.x · Cited by 3

Addressing the Complex Etiology of Alzheimer‘s Disease: the Role of P25/Cdk5

Mungenast, A. E., & Tsai, L. (2011) · Future Neurology · doi:10.2217/fnl.11.22 · Cited by 3

Influence of Phospholipids and Sequential Kinase Activities on Tau in Vitro

SHEA, T. B., & Ekinci, F. J. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4869-0_11 · Cited by 3

τ Protein and the Neurofibrillary Pathology of Alzheimer’s Disease

Goedert, M., Trojanowski, J. Q., & Lee, V. M. ‐. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_12 · Cited by 3

Neurochemical Aspects of Alzheimer Disease

Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_1 · Cited by 2

Alzheimer's disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk

Sjölander (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000203 · Cited by 2

Cdk5 as a Drug Target for Alzheimer’s Disease

Lau, L., & Hicks, C. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-78887-6_18 · Cited by 2

The Amyloid _-Protein and Alzheimer's Disease

Teplow, D. B., Yang, M., Roychaudhuri, R., Pang, E. S., Huynh, T. V., Chen, M., & Beroukhim, S. (2012) · Frontiers in neuroscience · doi:10.1201/b11986-2 · Cited by 2

Chronic Sustained Hypoxia Leads to Brainstem Tauopathy and Declines the Power of Rhythms in the Ventrolateral Medulla: Shedding Light on a Possible Mechanism

Khalilpour, J., Zangbar, H. S., Alipour, M. R., Pakdel, F. Q., Zavari, Z., & Shahabi, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03763-4 · Cited by 2

Phosphorylation of Tau and Its Relationship with Alzheimer Paired Helical Filaments

Mandelkow�, E., Biernat, J., Lichtenberg-Kraag, B., Drewes, G., Wille, H., Gustke, N., Baumann, K., & Mandelkow�, E. (1995) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-79423-0_10 · Cited by 1

Alzheimer’s Disease: effect of Tau-related genes on the pathology, neurochemistry and risk of disease

Sjölander, A. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1

Potential Role of Hyperactivation of Signal Transduction Pathways in Alzheimer’s Disease: Protein Kinase C Regulates PHF-like Phosphorylation of Tau within Neuronal Cells

Shea, T. B., Boyce, J. J., & Cressman, C. M. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_54 · Cited by 1

Metabolic Abnormalities in Alzheimer Disease

Gebhardt, F. M., & Dodd, P. R. (2008) · Springer eBooks · doi:10.1007/978-0-387-79112-8_22 · Cited by 1

Reelin and Cyclin-Dependent Kinase 5

Ohshima, T. (2008) · Springer eBooks · doi:10.1007/978-0-387-76761-1_9

Behandlung mit CDK5 Inhibitor bei der Myelin Oligodendrozyten Glykoprotein (MOG) induzierten experimentellen autoimmunen Encephalomyelitis (EAE)

Herlan, S. (2011)

Molecular Genetics and Molecular Biology of Alzheimer’s Disease

Sandbrink, R., & Beyreuther, K. T. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_72

Cdk5 and Neuregulin-1 Signaling

Wen, Y., Yu, W. H., & Duff, K. (2008) · Springer eBooks · doi:10.1007/978-0-387-78887-6_10

Tau Phosphorylation and Dephosphorylation in the Pathogenesis of Alzheimer’s Disease

Mawal-Dewan, M., Trojanowski, J. Q., & Lee, V. M.-Y. (1996) · Springer eBooks · doi:10.1007/978-3-662-03248-0_7 · Cited by 1

Regulation of synaptic function and plasticity by cyclin-dependent kinase 5

Su, S. C. (2012) · DSpace@MIT (Massachusetts Institute of Technology)

Protein–Protein Interactions Involving the N-Terminus of p35

Ng, G. K. H., He, L., & Qi, R. (2008) · Springer eBooks · doi:10.1007/978-0-387-78887-6_12

Pharmacodynamic Mechanisms of Tolfenamic Acid Induced SP1 Degradation Relative to Alzheimer's Disease Pathology

Adwan, L. I. (2013) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-adwan-lina-2013

In vitro modelling of tau phosphorylating kinases : emphasis of Cdk5

Jämsä, A. (2007) · Figshare

Role of P70 S6 kinase in the formation of tau pathologies in Alzheimer´s disease

An, W. (2005) · Figshare

Glial cell reactivity in mouse models reflecting different aspects of Alzheimer's disease

Behrendt, M. G. (2012) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.14767

P2‐143: Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase‐A

Zhu, L., Liu, X.-A., & Wang, J. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.1216

Epigenetic Mechanisms Regulating Memory Formation in Health and Disease

Tsai, L. (2012) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-27913-3_9

Effect of cycline-dependent kinase and matrix metalloproteinase inhibitors on hematopoietic and leukemic cells

Song, H. (2008) · Figshare

Two to Tangle: The Story of Tau and a-Synuclein

Sharma, N. (2005) · Eukaryon

SilencingofCDK5ReducesNeurofibrillaryTanglesin TransgenicAlzheimer'sMice

Manjunath, B. S. (2010)

Pathological Changes in the Elderly Human Brain

Mann, D. M. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6001-2_2

The Effect of Continuous Aerobic Exercise on Neurodegeneration in Diabetic Rats

Omidi, M., Ghanbarzadeh, M., Nikbakht, M., Habibi, A., & Rangbar, R. (2018) · Annals of Military and Health Sciences Research · doi:10.5812/amh.85194

Tau Protein and the Neurofibrillary Pathology of Alzheimer’s Disease

Goedert, M. (1996) · Springer eBooks · doi:10.1007/978-3-642-80109-9_9 · Cited by 1

Regulatory properties of neuronal cdc2-like kinase

Qi, R. Z., Tang, D., Matsuura, I., Lee, K., Zhu, X., Huang, Q., & Wang, J. H.-C. (1995) · Springer eBooks · doi:10.1007/978-1-4615-2015-3_4

Chapter 4. Transgenic Mice Overexpressing GSK-3β as Animal Models for Alzheimer's Disease

Hernández, F. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732758-00052

A study of the role of presenilin (1) in regulating synaptic function at hippocampal synapses

Yu, L. M. Y. (2010) · UCL Discovery (University College London)

Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer

Laumet, G. O. (2010) · theses.fr (ABES) · doi:10.70675/94126786zf990z488ezb471z5f1d5686766c

p35/cdk5 binds and phosphorylates β‐catenin and regulates β‐catenin/presenilin‐1 interaction

Kesavapany, S., Lau, K., McLoughlin, D. M., Brownlees, J., Ackerley, S., Leigh, P. N., Shaw, C. E., & Miller, C. C. J. (2001) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2001.01376.x

BindingDB Entry 919: Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25.

BindingDB (2006) · UC San Diego · doi:10.7270/q2cr5rjs

BindingDB Entry 4258: Defining Cdk5 ligand chemical space with small molecule inhibitors of tau phosphorylation.

BindingDB (2011) · UC San Diego · doi:10.7270/q2st7n84

Molekulargenetik und Molekularbiologie der Alzheimer-Krankheit

Sandbrink, R., & Beyreuther, K. T. (1999) · Springer eBooks · doi:10.1007/978-3-642-60175-0_7

Microtubules, Tau Protein,and Paired Helical Filaments in Alzheimer’s Disease

Mandelkow�, E., Biernat, J., Lichtenberg-Kraag, B., Drewes, G., Wille, H., Gustke, N., Baumann, K., & Mandelkow�, E. (1995) · Springer eBooks · doi:10.1007/978-3-642-79482-7_16

Untitled work

Shinpo (2000) · doi:10.1002/1097-4547(20001101)62:3

Proline-directed phosphorylation of human Tau protein.

Vulliet, R., Halloran, S. M., Braun, R., Smith, A. J., & Lee, G. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41710-3 · Cited by 163

The Regulatory Ser262 of Microtubule-associated Protein Tau Is Phosphorylated by Phosphorylase Kinase

Paudel, H. K. (1997) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67481-8 · Cited by 65

P2‐149: The role of protein kinase A in coordinating tau phosphorylation state relevant to Alzheimer's disease

Seereeram, A., Siemann, M., Anderton, B. H., & Hanger, D. P. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.1222

Comparison of the phosphorylation of microtubule-associated protein tau by non-proline dependent protein kinases

Singh, J., Grundke, I., McDonald, B., & Iqbal, K. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00925955 · Cited by 53

Protein Kinase FA/GSK‐3 Phosphorylates on Ser235‐Pro and Ser404‐Pro that Are Abnormally Phosphorylated in Alzheimer's Disease Brain

Yang, S., Song, J., Yu, J., & Shiah, S. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09811.x · Cited by 78